Dr Nazar Vasyliv (MD MSc CEO)
PhD candidate
- Centre for Clinical Brain Scienses
- Affiliation- Wolfson Wohl Cancer Research Centre
- Affiliation-The Beatson Institute for Cancer Research
Contact details
- Email: N.Vasyliv@sms.ed.ac.uk
Address
- Street
-
Centre for Clinical Brain Sciences
49 Little France Crescent - City
- Edinburgh
- Post code
- EH16 4SB
- Street
-
Wolfson Wohl Cancer Research Centre
School of Cancer Sciences
University of Glasgow
Garscube Estate
Switchback Road - City
- Bearsden
- Post code
- G61 1QH
Background
Dr. Nazar Vasyliv is an academic neurosurgeon and researcher with a profound dedication to advancing the fields of neurosurgery, oncology, and precision medicine. His journey into the medical world began at Ivano-Frankivsk National Medical University in Ukraine, where he earned his medical diploma in 2014. His early passion for neurosurgery led him to the Romodanov Institute of Neurosurgery in Kyiv, from August 2014 to August 2020.
During his training at the Romodanov Institute, Dr. Vasyliv honed his skills under the mentorship of esteemed neurosurgeons, gaining comprehensive experience in both clinical and surgical settings. His dedication and skill were further demonstrated when he took on the role of junior neurosurgeon at the same institute from September 2020 to August 2021.
Dr. Vasyliv's commitment to professional growth and learning led him to seek advanced training and specialised programmes across Europe and Asia. Notably, he trained at Liv Hospital in Istanbul, Turkey, under the guidance of Professor Talat Kiris, the Past President of the Turkish Neurosurgical Society. Under Professor Kiris, he mastered advanced neurosurgical techniques, including fluorescein-guided neurosurgery, which significantly improved his surgical precision and patient outcomes. He also participated in the European Project on the Development of Epilepsy Surgery Programmes (EPODES) in Brno, Czech Republic, and undertook clinical fellowships in neuro-oncology and epilepsy surgery at Namik Kemal University in Tekirdag, Turkey.
In addition to his European training, Dr. Vasyliv expanded his expertise globally through the WFNS skull-base fellowship at Hinduja Hospital in Mumbai, India. Under the mentorship of Professor Basant Misra, the Vice-President of the World Federation of Skull Base Societies, he gained advanced skills in skull-base neurosurgery. This fellowship, from May to July 2018, provided him with invaluable experience in managing complex cranial base pathologies and enhanced his surgical repertoire significantly.
In 2022, Dr. Vasyliv furthered his academic pursuits by completing a Master of Science in Cancer Research and Precision Oncology at the University of Glasgow. His MSc thesis, "Effect of Photodynamic Therapy on Glioblastoma Cell Lines," was supervised by leading experts in the field and explored innovative treatments for glioblastoma, a highly aggressive form of brain cancer. This research underscored the potential of photodynamic therapy as a promising approach for targeting and treating brain tumours.
Currently, Dr. Vasyliv is a PhD candidate at the University of Edinburgh, within the Department of Clinical Brain Sciences, with an affiliation to the University of Glasgow and the Wolfson Wohl Cancer Research Centre. His doctoral research focuses on developing novel strategies for treating brain tumours, emphasising molecular mechanisms and targeted therapies after photodynamic therapy.
Dr. Vasyliv has made significant contributions to the scientific community through his numerous publications and presentations at international conferences. His work has been recognised at prestigious events such as the European Society for Stereotactic and Functional Neurosurgery and the World Society for Stereotactic and Functional Neurosurgery. His research on the effectiveness of differentiated surgical treatment for Parkinson's disease and the analysis of epileptic seizures post-surgery has been widely acclaimed.
Beyond his research, Dr. Vasyliv is an active member of several professional organisations, including the European Society of Photobiology and the American Association for Cancer Research. He also serves as the Chief Editor for the Neurosurgery section of the Medical and Research (MAR) journal, playing a pivotal role in disseminating cutting-edge research to the medical community. Dr. Nazar is CEO of Global Alliance for Neurosurgical & Brain Cancer Research Innovations.
CV
141613.pdfResponsibilities & affiliations
The Beatson Institute for Cancer Research
Invited speaker
Oral communication was presented in Lyon, France at the 20th Congress of the European Society of Photobiology, August 27th-31st. "New outlook on photodynamic therapy for glioblastoma cell lines".
More video
- https://www.medicalandresearch.com/journal/Journal-of-MAR-Neurology,-Neuro-surge…
- Is Bilateral Ablative Surgery for Parkinson’s Disease Still Effective? Long- Term Follow-Up Control Study of 394 Patients
- Photodynamic therapy improves therapeutic management of glioblastoma
- Targeting Glioblastoma: Inducing Necroptosis molecular pathway Post-PDT for Enhanced Neurosurgical and Therapeutic Outcomes